Roberta Bonafe

Dr. Roberta Bonafe

BRACCO IMAGING SPA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre
RARachida Aid-Launais
Rachida Aid-Launais
JAJoël Aerts
Joël Aerts
Frederic ChaubetFrederic Chaubet
Frederic Chaubet
MMMurielle Maire
Murielle Maire
Didier LetourneurDidier Letourneur
Didier Letourneur
The adhesion molecule P-selectin is present on the cell surface of both activated endothelium and activated platelets. The present study describes the pharmaceutical development, safety evaluation, and preclinical efficacy of a micro-dosed radiotracer. The macromolecular nanoscale assembly consisted of a natural compound made of a sulfated fucose-rich polysaccharides (fucoidan) and a radionuclide (technetium-99m) for the detection of P-selectin expression in cardiovascular diseases. After extraction and fractionation from brown seaweeds, the good manufacturing practice (GMP) production of a low molecular weight (LMW) fucoidan of 7 kDa was achieved and full physicochemical characterization was performed. The regulatory toxicology study in rats of the GMP batch of LMW fucoidan revealed no adverse effects up to 400 μg/kg (×500 higher than the expected human dose) and pseudoallergy was not seen as well. In a myocardial ischemia-reperfusion model in rats, the GMP-grade LMW fucoidan labeled with technetium-99m detected P-selectin upregulation in vivo. The present study supports the potential of using 99mTc-fucoidan as an imaging agent to detect activated endothelium in humans.

1 February 2018 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
SBSimona Bussi
Simona Bussi
LPLaure Penard
Laure Penard
RBRoberta Bonafe
Roberta Bonafe
CBCatherine Botteron
Catherine Botteron
RCRoberto Celeste
Roberto Celeste
FMFederico Maisano
Federico Maisano
To determine the impact of single and cumulative doses of MultiHance on toxicity, pharmacokinetics, tissue gadolinium presence, behavior and neurological function in juvenile rats. Juvenile male and female rats received either physiological saline or MultiHance at 0.6, 1.25 or 2.5 mmol/kg bodyweight. Animals received either single or six consecutive MultiHance administrations and were sacrificed the day after the last administration or after a 60-day treatment-free period. Animals were assessed for behavior, cognitive function, grip strength, gait, pupillary reflex, and auditory reflex, as well as for physical development, sexual maturation and histopathology. Gadolinium presence in brain, femur, kidneys, liver and skin was determined using inductively coupled plasma-mass spectrometry (ICP-MS). No effects of MultiHance on behavior, cognitive function or any other parameter were noted, even for the highest administered cumulative dose (15 mmol/kg). Gadolinium presence was variable across tissues and decreased during the 60-day treatment-free period. The highest levels were noted in the femur and the lowest levels in the brain. Gadolinium presence in juvenile rat brain following single or repeated MultiHance administrations was minimal and non-impactful.

5 October 2008 in Toxicology Letters
Verified
Journal Article
Closed access
RBRoberta Bonafe
Roberta Bonafe
PBPaola Bardini
Paola Bardini
SBSimona Bussi
Simona Bussi
AMAlessandro Maiocchi
Alessandro Maiocchi